Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.

× No keyword cloud information.

7 in total

1. Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania.

Authors: Catherine Dotchin; Ahmed Jusabani; Richard Walker
Journal: J Neurol Date: 2011-03-26 Impact factor: 4.849

Review 2. Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Authors: M G Murer; R Raisman-Vozari; O Gershanik
Journal: Drug Saf Date: 1999-11 Impact factor: 5.606

3. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.

Authors: Han Soo Yoo; Seok Jong Chung; Su Jin Chung; Hyojeong Moon; Jung Su Oh; Jae Seung Kim; Jin Yong Hong; Byoung Seok Ye; Young Ho Sohn; Phil Hyu Lee
Journal: Eur J Nucl Med Mol Imaging Date: 2017-10-26 Impact factor: 9.236

4. Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.

Authors: Mario Gustavo Murer; Rosario Moratalla
Journal: Front Neuroanat Date: 2011-08-11 Impact factor: 3.856

Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.

1. Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania.

Review 2. Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

3. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.

4. Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.

5. Analysis of factors associated with brittle response in patients with Parkinson's disease.

6. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

7. Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease.